1. Background {#sec1}
=============

Nosocomial infections with *Enterococci* are a major concern at many hospitals and have been rapidly increasing in many countries worldwide \[[@B1]\]. *Enterococci* are well known antibiotic-resistant opportunistic pathogens commonly recovered from patients who received multiple courses of antibiotics and hospitalized for prolonged periods \[[@B2]\]. They are the second more frequently reported cause of surgical wound infection and nosocomial urinary tract infection (UTI) and the third most frequently reported cause of bacteremia \[[@B1], [@B3]\]. Especially, *Enterococcus faecalis* and *Enterococcus faecium* have become causes of international concern from the genus \[[@B4]\].

Vancomycin-resistant *enterococci* (VRE) belong to the most important nosocomial pathogens worldwide, and they usually cause infections in severely debilitated, immunocompromised patients, like HIV-infected patients, who undergo prolong intensive antibiotic therapy \[[@B1]\]. The acquisition of VRE has seriously affected the treatment and infection control of these organisms. VRE particularly *E. faecium* strains are frequently resistant to all antibiotics that are effective treatment for vancomycin-susceptible *Enterococci*, which leave clinicians treating VRE infections with limited therapeutic options \[[@B5]\].

Various risk factors for VRE colonization were reported before, including previous exposure to multiple antibiotics \[[@B6]\], presence of previous hospitalization, and prolonged duration of vancomycin use (≥7 days) \[[@B7]\]; catheterizations; comorbid conditions such as renal failure; underlying diseases like diabetes; and presence of surgical procedure \[[@B2], [@B8]\].

Due to high level of resistance to multiple antimicrobial agents, *Enterococcus* becomes important in health facility-based settings. HIV-infected patients who were repeatedly exposed to the healthcare environment had higher VRE colonization than other groups \[[@B9]\]. Data regarding the magnitude of VRE and its associated factors have been released at different health facilities; however, these data are missing in our study site. Therefore, this study was conducted to determine the prevalence of VRE colonization among HIV-positive patients attending ART clinic at West Amhara Government Hospitals.

2. Methods and Materials {#sec2}
========================

2.1. Study Design, Setting, and Period {#sec2.1}
--------------------------------------

A cross-sectional study was conducted among HIV-infected patients visiting randomly the selected three government hospitals in *Amhara* regional State (Debre Markos Referral Hospital (DMRH), Debre Tabor General Hospital (DGH), and Felege hiwot Referral Hospital (FHRH)) from 1 February 2017 to 31 May 2017. The hospitals, located in the northwest part of Ethiopia, were providing different healthcare services, like emergency, inpatient, and outpatient services for about 12 million people.

2.2. Sample Size, Sampling Method, and Population {#sec2.2}
-------------------------------------------------

Sample size was determined using Epi info version 3.5.1 considering 95% confidence level, 5% marginal error, and VRE prevalence of at 7.8% \[[@B10]\], making the total sample size 349. Almost an equal number of participants were taken from each hospital for convenience even though the hospitals had different number of HIV patients in their respective ART clinics: from DGH (*n*=114), DMRH (*n*=117), and FHRH (*n*=118). Systematic random sampling technique was used to select study participants. Our sampling frame was the appointment log book of ART patients. Each participant was selected using a random number table based on their appearance from the appointment log book. Those HIV patients under antibiotics treatment within two weeks at the time of data collection were excluded from the study as stated previously \[[@B11]\].

2.3. Data Collection {#sec2.3}
--------------------

Sociodemographic data and related clinical data suggested to be connected with VRE colonization were collected using the pretested interview-based structured questionnaire.

### 2.3.1. Stool Sample Collection and Transportation {#sec2.3.1}

Patients were instructed and provided with wide-mouthed, sterile plastic containers to bring about 5--10 g stool specimens. The collected stool specimen from each hospital was transported to Amhara Public Health Institute (APHI) using Carry Blair Transport Medium (OXOID LTD, UK). Immediately after collection, approximately one gram of the fecal specimen was placed on a medium and stored in 2--8°C, until transported to the laboratory for processing.

### 2.3.2. Bacterial Isolation and Identification {#sec2.3.2}

Stool samples were streaked on Bile Esculin Azide Agar (BEAA) (Hardy Diagnostics, Santa Maria, USA) and incubated for 24 hours at 37°C. Plates were observed for appearance of characteristic colonies with dark halo center. Characteristic colonies were selected randomly for characterization and identified presumptively as *Enterococci* \[[@B12]\] by the following phenotypic tests: (a) Gram stains; only plates that yield Gram-positive cocci in pairs or short chains were studied further. (b) Catalase test; catalase test was performed on suspected colonies according to standard microbiological procedure \[[@B12]\] and only microbial growth which yield negative result for catalase production were considered further. (c) Growth in 6.5% NaCl; similar colonies from each plate were picked and inoculated in to brain heart infusion (BHI) broth (OXOID LTD, UK) containing 6.5% NaCl and incubated at 37°C for 24--48 hours, and growth in the medium were indicated by turbidity \[[@B13]\]. (d) Growth at 45°C; colonies were picked, inoculated into BHI broth, and incubated at 45°C for 24 hours, and growth in the medium were indicated by turbidity. An isolate fulfilling the above criteria were considered as an *Enterococcus* species \[[@B12]\]. For further identification, stock cultures were stored at BHI broth containing 50% glycerol (Biochemica Synthesis Service, Germany) at −20°C.

### 2.3.3. Antimicrobial Susceptibility Testing {#sec2.3.3}

Antimicrobial susceptibility testing for each isolate was performed using the Kirby--Bauer disk diffusion method on Muller--Hinton agar (OXOID, UK). From pure culture, selected colonies of bacteria were taken and transferred to a tube containing sterile nutrient broth (OXOID, UK) and incubated at 37°C until the turbidity of the suspension becomes adjusted to a McFarland standard (Hardy diagnostics, Canada) 0.5. Then, the suspension was spread evenly on Muller--Hinton agar based on Clinical and Laboratory Standards Institute (CLIS). The medium after exposed to a concentration gradient of antibiotic discs were incubated at 37°C for 18--24 hours. Grades of susceptibility pattern were recognized as sensitive and resistant by comparison of zone of inhibition according to the CLSI guidelines. Antimicrobial susceptibility patterns of *Enterococci* were assessed against the following antibiotic discs: vancomycin (30 *μ*g), ampicillin (10 *μ*g), nitrofurantoin (300 *μ*g), tetracycline (30 *μ*g), ciprofloxacin (5 *μ*g), chloramphenicol (30 *μ*g), erythromycin (15 *μ*g), norfloxacin (30 *μ*g), and doxycycline (30 *μ*g) (all from Abtek Biologicals Ltd.).

2.4. Quality Control {#sec2.4}
--------------------

The reliability of the study findings was guaranteed by implementing the standard quality measures through the whole process of the laboratory work and data collection. All culture media were prepared following the manufacturer\'s instruction. The batch of prepared media was checked for sterility by incubating the plate at 37°C for 24 hrs. Moreover, *E. faecalis* ATCC 29212 and *Staphylococcus aureus* ATCC 25923 standard strains were used as a quality control \[[@B14]\].

2.5. Data Analysis {#sec2.5}
------------------

Collected data were entered, cleared, and analyzed using the SPSS statistical software package, Version 23.0 (IBM Corp. Released 2011. IBM SPSS Statistics for Windows. Armonk, NY: IBM Corp.). Descriptive analysis such as proportion, median, and variance were used to visualize differences within data. Moreover, stepwise logistic regression model was used to assess factors associated with VRE colonization in terms of the odds ratio and its 95% confidence interval (CI). *P* value was set at 0.05 to indicate statistical significance difference.

3. Ethical Approval {#sec3}
===================

Ethical clearance was obtained from Bihar Dar University college of Medicine and health ethical review board (IRB). Official permission and an informed written consent were obtained from the hospitals and each study participant, respectively. The consent of children was obtained from their family or guardian. The confidentiality of the information was maintained. The VRE positive results were communicated to their physicians for appropriate management.

4. Results {#sec4}
==========

4.1. Sociodemographic Characteristics {#sec4.1}
-------------------------------------

A total of 349 study participants were included in this study, of which, 202 (57.9%), were females. The mean age of the patients was at 36.4 years with standard deviation of 12.9 years. Majority of the study participants, 268 (76.8%), came from urban settings. Less than half of the participants were illiterate (133 \[38.1%\]) and married (151 \[43.3%\]) ([Table 1](#tab1){ref-type="table"}).

4.2. Prevalence of VRE Colonization {#sec4.2}
-----------------------------------

Among the 349 study participants, *Enterococci* were isolated from 220 (63%), of which, 67 (30.5%) were from FHRH, 71 (32.3%) from DGH, and 82 (37.3%) from DMRH. In turn, amongst the total 220 isolates of *Enterococci*, 17/220 (7.7% (95% CI: 4.9--12.0)) were VRE. Proportion of VRE from FHRH, DGH, and DMRH was 4 (6.0%), 7 (9.9%), and 6 (7.3%), respectively.

4.3. Antimicrobial Resistance Profile of *Enterococci* {#sec4.3}
------------------------------------------------------

Of the total 220 *Enterococcal* isolates tested against the commonly available antimicrobial agents, 142 (64.5%) were found apparently resistant to two or more antimicrobials. Specifically, 94 (42.7%) were found resistant to erythromycin. Moreover, 83 (37.7%) and 68 (30.9%) *Enterococcal* isolates were reported to be resistant to tetracycline and doxycycline, respectively (Tables [2](#tab2){ref-type="table"} and [3](#tab3){ref-type="table"}).

4.4. Factors Associated with VRE {#sec4.4}
--------------------------------

All sociodemographic characteristics of the study participants such as sex, age, educational status, residence address, and marital status were not found associated with VRE colonization (*p* value \> 0.05). However, most of VRE were isolated from female participants, patients aged \>25 years, and HIV patients who came from urban setting ([Table 4](#tab4){ref-type="table"}). In the multiple logistic regression model, patients with history of hospital admission in the last six month and patients having history of previous administration of antibiotics \>2 weeks had \>20 (AOR = 20.17; (95% CI: 5.22--77.93)) times and \>10 (AOR = 10.18, (95% CI: 1.9--53.20)) times more likely to be colonized with VRE as compared with their counterparts. However, the remaining variables didn\'t show statistical significance difference (*p* value \> 0.05) ([Table 5](#tab5){ref-type="table"}).

5. Discussion {#sec5}
=============

The rapid emergence of drug resistant *Enterococci* and the increasing incidence of colonization with VRE have become healthcare issues that have caused serious concern to physicians and health authorities \[[@B15]\]. In the present study, we included study participants from three government hospitals, which cover different geographic areas. The overall prevalence of *Enterococci* colonization in this study was at 63%, which is higher than previous reports from different hospitals in Ethiopia such as in Jimma (0.59%) \[[@B16]\], Felege Hiwot (0.64%) \[[@B17]\] and University of Gondar Teaching hospital (2.13%) \[[@B18]\]. Another study also reported higher *Enterococcal* isolates of 125 (78.12%) *Enterococcus faecalis* and 35 (21.88%) *Enterococcus faecium* \[[@B19]\]. The difference might be due to the use of *Enterococci* selective media in the present study which might increase the chance of isolation. On top of this all of our study participants were HIV positive patients in which *Enterococci* colonization is much likely due to their compromised immune system. Moreover, the gradual increase of *Enterococci* infection might have contributed to the increased prevalence as evidenced by other studies \[[@B20]\]. However, our finding was lower than reports from elsewhere in the World like, Egypt at (82.83%) \[[@B21]\] and Hijazii in hospitalized patients at (94%) \[[@B22]\].

The overall prevalence of VRE in this study was 7.7%, which is in line with reports from government medical collage Seurat (8%) \[[@B15]\]. However, it was lower than from a report in Taiwan (11.3%) \[[@B23]\], southern Iran (22%) \[[@B24]\] and Shiraz (14.7%) \[[@B25]\]. The lower prevalence in the present study might be due to the variation in the study participants and the methods employed for detection.

On the other hand, the prevalence VRE in the present study was higher than a report from Konkuk University School of Medicine, Seoul (4.5%) \[[@B22]\] and Iran (4.38%) \[[@B26]\]. This deference might be attributed by the variation in the study population where most of the study participants in the present study had habit of animal contact and this was supported by Bekele and Ashenafi that reported 100% VRE from faces of chicken and cattle in Ethiopia \[[@B27]\].

The *Enterococci* isolates in the present study were found variably resistant against the tested antibiotics such as ampicillin at (20.9%) erythromycin (42.7%) doxycycline (27.7%), tetracycline (28.6%), ciprofloxacin (37.7%) and chloramphenicol at (30.9%). The resistance profile reported in the present study was higher than a previous study in Gondar \[[@B18]\]. This variation might be due to the fact that we are in the time of gradual change in the antibiotic resistance pattern of isolates. However, the antimicrobial resistance profile observed in this study was found less than a previous study done in Iraq against ampicillin (71.4%), ciprofloxacilin (71.5%) \[[@B28]\] and erythromycin (73.12%) \[[@B19]\]. In the later study, the participants were all hospitalized patients who were taking different antibiotics that might be contributed for emergence of high rate of drug resistant microorganisms including *Enterococci* compared with other patients.

Moreover, our study showed that all VRE isolates were resistant to ampicillin and were multidrug resistant (MDR). This result was in line with the previous finding in Gondar, Ethiopia \[[@B10]\]. In contrast, the *Enterococci* isolates of this study showed relatively better sensitivity for nitrofurantoin than to vancomycin, norfloxacin, ampicillin, ciprofloxacin, and chloramphenicol. This finding was also supported by a previous report in Egypt \[[@B21]\].

With regard to the associated factors assessed for VRE colonization, patients with history of hospital admission in the last six months had about 20 times more likely the chance of getting VRE colonization as compared with those with no recent history of hospital admission in the last six months (*P* value \< 0.001). This result was comparable with reports from Spain \[[@B29]\]. This study also showed that prevalence of VRE colonization with patients having history of previous administration of antibiotics greater than two weeks had 10 times more likely had the chance of getting VRE colonization as compared with those with no history of previous administration of any antibiotics (*P* value \< 0.012). Similar reports from Gondar, Ethiopia, showed that antibiotic exposure can cause the emergence of VRE and creates for the survival of *Enterococci* in hospital environment due to their intrinsic resistance to several commonly used antibiotics and their ability to acquire resistance genes \[[@B10]\]. The rest variables tested in the model did not show statistical significant difference (*P* value \> 0.05). Of course, similar finding was reported in the US \[[@B9]\].

Due to resource constraints, it was not possible to determine the different species of *Enterococci* which might all have a determinant factor to show the complete picture of the isolates in the studied area.

6. Conclusions {#sec6}
==============

The emergence of VRE linked with multidrug resistance was observed in this study. Hence, a periodic surveillance on antibiogram of VRE in hospitals is essential to contain the spread of antimicrobial resistance. Efforts should also be made to prevent VRE colonization of patients with immunesuppression.
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###### 

Sociodemographic characteristics of study participants (*n*=349) at the West Amhara Government Hospitals, May, 2017.

  Sociodemographic characteristics   Frequency (%)
  ---------------------------------- ---------------
  *Sex*                               
  Female                             147 (42.1)
  Male                               202 (57.9)
                                     
  *Age in years*                      
  \<9                                8 (2.3)
  10--14                             18 (5.2)
  15--24                             34 (9.7)
  25--59                             275 (78.8)
  60+                                14 (4.0)
                                     
  *Residence addresses*               
  Urban                              268 (76.8)
  Rural                              81 (23.2)
                                     
  *Educational status*                
  Illiterate                         133 (38.1)
  Primary school                     120 (34.4)
  Secondary school                   57 (16.3)
  Above high school                  39 (11.2)
                                     
  *Marital status*                    
  Single                             87 (24.9)
  Married                            151 (43.3)
  Divorced                           79 (22.6)
  Widowed                            32 (9.2)
                                     
  *Total*                            349 (100)

###### 

Antimicrobial resistance profile of *Enterococci* among ART patients at West Amhara Government Hospitals, May, 2017 (*n*=220).

  Antimicrobial agents   Susceptible, *N* (%)   Resistant, *N* (%)
  ---------------------- ---------------------- --------------------
  Vancomycin             203 (92.3)             17 (7.7)
  Ampicillin             174 (79.1)             46 (20.9)
  Nitrofurantoin         214 (97.3)             6 (2.7)
  Chloramphenicol        152 (69.1)             68 (30.9)
  Tetracycline           157 (71.4)             63 (28.6)
  Doxycycline            159 (72.3)             61 (27.7)
  Erythromycin           126 (57.3)             94 (42.7)
  Norfloxacin            184 (83.6)             36 (16.4)
  Ciprofloxacin          137 (62.3)             83 (37.7)

###### 

Profile of multidrug-resistant pattern of VRE (*n*=17) among ART patients in West Amhara Government Hospitals, May, 2017.

  Resistance rate   Combination of antibiotics               Number of isolates tested
  ----------------- ---------------------------------------- ---------------------------
  R3                VAN, AMP, CHL                            2
  R3                VAN, AMP, ERY                            2
  R3                VAN, AMP, NOR                            1
  R4                VAN, AMP, TET, DOC                       1
  R5                VAN, AMP, TET, ERY, DOC                  1
  R5                VAN, AMP, CIP, CHL, ERY                  1
  R5                VAN, AMP, CIP, ERY, NOR                  1
  R6                VAN, AMP, TET, CIP, NOR, DOC             1
  R6                VAN, AMP, TET, CIP, ERY, DOC             3
  R6                VAN, AMP, NIT, CIP, CHL, ERY             1
  R6                VAN, AMP, TET, CIP, NOR, DOC             1
  R7                VAN, AMP, NIT, TET, CIP, CHL, DOC        1
  R8                VAN, AMP, TET, CIP, CHL, ERY, NOR, DOC   1
  Total                                                      17

ERY, erythromycin; TET, tetracycline; AMP, ampicillin; VAN, vancomycin; DOC, doxycycline; NIT, nitrofurantoin; CIP, ciprofloxacin; NOR, norfloxacin; CHL, chloramphenicol; *R*, resistance. *R*3--*R*8 = number of antibiotic-resistant isolates from 3 to 8, respectively. MDR = organisms resistant to ≥2 antibiotics.

###### 

Sociodemographic characteristics and prevalence of VRE among ART patients in West Amhara Government Hospitals, May, 2017.

  Demographic characteristics   Vancomycin   *P* value   
  ----------------------------- ------------ ----------- -------
  *Sex*                                                  
  Male                          89           5           0.254
  Female                        114          12          
                                                         
  *Age group*                                            
  \<9                           5            0           0.997
  10--14                        9            0           
  15--24                        19           2           
  25--59                        162          14          
  60+                           8            1           
                                                         
  *Residence address*                                    
  Urban                         156          14          0.604
  Rural                         47           3           
                                                         
  *Educational status*                                   
  Illiterates                   79           5           0.382
  Primary school (1--8)         66           10          
  Secondary school (9--12)      35           2           
  Above high school             23           0           
                                                         
  *Marital status*                                       
  Single                        52           3           0.804
  Married                       85           9           
  Divorced                      48           4           
  Widowed                       18           1           

###### 

Multiple logistic regression analysis of prevalence of VRE colonization at West Amhara Government Hospitals, May, 2017.

  Risk factor                                          Category    Vancomycin   COR (95% CI)          AOR (95% CI)          *P* value   
  ---------------------------------------------------- ----------- ------------ --------------------- --------------------- ----------- -------
  Pervious antibiotic treatment (\>2 weeks)            No          97           2                     1                                 0.012
  Yes                                                  106         15           6.86 (1.53--30.79)    10.18 (1.95--53.20)               
                                                                                                                                        
  History of hospital admission in the last 6 months   No          193          10                    1                                 0.001
  Yes                                                  10          7            13.51 (4.25--42.94)   20.17 (5.22--77.93)               
                                                                                                                                        
  HAART duration                                       \<2 years   11           3                     1                                 0.92
  \>2 years                                            192         14           3.74 (0.934--14.97)   ---                               
                                                                                                                                        
  Renal failure                                        No          196          15                    1                                 0.319
  Yes                                                  7           2            3.73 (0.71--19.57)    ---                               
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